A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc)

NCT01775761 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

TTR Cardiomyopathy

Interventions

DRUG: Period 1
DRUG: Period 2
DRUG: Period 3

Sponsor

Pfizer